Atomwise
Atomwise Inc.
Atomwise Inc. is a pioneering technology-enabled pharmaceutical company that employs artificial intelligence to transform the landscape of small molecule drug discovery. By leveraging advanced machine learning techniques, Atomwise aims to streamline the drug development process, making it not only more efficient but also more effective in identifying viable therapeutic candidates.
Products & Team
AtomNet
AtomNet is an advanced AI-powered drug discovery platform that utilizes deep learning algorithms and convolutional neural networks to predict interactions between small molecules and protein targets. This cutting-edge technology enables the virtual screening of billions of chemical compounds, rapidly identifying the most promising candidates for further development.
AtomNet addresses the inefficiencies of traditional drug discovery methods by accelerating the identification of effective drug candidates, thus significantly reducing both the time and costs involved in the drug development process.
Traditional drug discovery processes are often slow, costly, and suffer from low success rates when it comes to developing new therapeutics. Atomwise addresses these challenges by providing a faster and more efficient alternative.